Latest News
Acute COPD Exacerbation Frequency May Not Be Accurate Guide for Treatment
Study to Examine Efficacy of Canakinumab in COVID-19 With Acute Myocardial Injury
COVID-19: Assessing Antibody Responses and Clinical Outcomes in Severe Disease
Icatibant Treatment Improves Oxygenation in COVID-19 Patients
Medical Care Avoidance Found Because of COVID-19 Concerns
Late Life Disability Instrument Can Assess Life Role Participation in COPD
Diagnosis and Treatment of Pulmonary Embolism in Patients With COVID-19
HRRP Implementation Reduced 30-Day All-Cause Readmission Rates in COPD
Baricitinib Plus Remdesivir Shortens Recovery Time for Hospitalized Patients With COVID-19
E-Cigarette Use Increased Significantly From 2017 to 2018
Young Adults With COVID-19 Have Substantial Rates of Adverse Outcomes
The Role of Artificial Intelligence in Pulmonary Imaging: Clinician Interview
Managing Sedation, Analgesia in Critically Ill Patients Receiving Naltrexone
Vascular Calcification in COPD Affects Bone Mineral Density, Increases Fractures
-
Proposed Palliative Care Response Plans During the COVID-19 Pandemic
Clinicians have proposed a system-wide response plan for the delivery of high-quality palliative care across a continuum of conventional, contingency, and crisis capacity scenarios during the COVID-19 pandemic. -
Could Respiratory Muscle Training Ease the Future COVID-19 Pandemic Burden?
Patients with COVID-19 who also have poor baseline health and/or obesity are more likely to demonstrate impaired respiratory muscle performance. -
Focus on Shared Ventilation Is "Missing the Point": Expert Roundtable
Specialists emphasized that although shared ventilation may be necessary in times of crisis, innovative alternatives should be used to avoid such extreme measures during the COVID-19 pandemic. -
Maintaining ICU, Hospital Infection Control During the COVID-19 Pandemic
Physicians and hospitals have urged the public to seek immediate medical care when needed, with reassurance regarding sound infection control practices that hospitals have implemented in light of the COVID-19 pandemic. -
Effect of COVID-19 on Pulmonary Fibrosis Clinical Trials: Expert Interview
Individuals with pulmonary fibrosis could develop more serious complications if infected with COVID-19, and those awaiting organ transplantation and other surgical interventions may face delays because of the pandemic. -
Pulmonary Hypertension With ILD: Diagnostic and Treatment Challenges
Although pulmonary hypertension as a result of interstitial lung disease is linked to significant morbidity and mortality, there is no consensus regarding screening or management of the disease. -
How Do Viruses Affect Asthma Development and Exacerbation?
Recent studies have led to important insights regarding the role of viruses in asthma pathogenesis and exacerbations, as well as mediating factors involved in these processes.
Latest Features
Ethical Considerations in Prescribing Unproven Therapies for COVID-19
Meeting public demand for an urgently needed effective medication quickly and safely during a pandemic involves difficult tradeoffs.
Lung Cancer in the Time of COVID-19: Challenges and Solutions
In the midst of the COVID-19 pandemic, patients with lung cancer face an increased risk of disease progression, reduced survival, and worse quality of life associated with delayed treatment.
How to Prepare Patients for the New Influenza Season During COVID-19 Pandemic
The Advisory Committee on Immunization Practices encourages all Americans to receive the flu vaccine between September and October.
-
Loading...
-
Loading...
